デフォルト表紙
市場調査レポート
商品コード
1089765

臨床試験マッチングソフトウェアの世界市場:展開別(クラウド・ウェブベース・オンプレミス)、最終用途別、地域別(南北アメリカ、アジア太平洋、欧州、中東・アフリカ)、2027年までの予測 - COVID-19の累積影響

Clinical Trials Matching Software Market Research Report by Deployment (Cloud & Web Based and On-Premise), End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 212 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
臨床試験マッチングソフトウェアの世界市場:展開別(クラウド・ウェブベース・オンプレミス)、最終用途別、地域別(南北アメリカ、アジア太平洋、欧州、中東・アフリカ)、2027年までの予測 - COVID-19の累積影響
出版日: 2022年06月15日
発行: 360iResearch LLP
ページ情報: 英文 212 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験マッチングソフトウェアの市場規模は、13.12%のCAGRで推移し、2027年までに3億6,072万米ドルに達すると予測されています。

当レポートでは、世界の臨床試験マッチングソフトウェア市場について調査し、市場の促進要因、抑制要因、市場機会、課題、展開別・最終用途別・地域別の市場分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーション・範囲
  • 調査対象期間
  • 通貨・価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 臨床試験マッチングソフトウェア市場:展開別

  • クラウド・ウェブベース
  • オンプレミス

第7章 臨床試験マッチングソフトウェア市場:最終用途別

  • 開発業務受託機関(CRO)
  • 医療機器企業
  • 製薬・バイオテクノロジー企業

第8章 南北アメリカの臨床試験マッチングソフトウェア市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋の臨床試験マッチングソフトウェア市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第10章 欧州、中東・アフリカの臨床試験マッチングソフトウェア市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意・コラボレーション・パートナーシップ
    • 新製品の発売・強化
    • 投資・資金調達
    • 評価・認知・拡大

第12章 企業のユーザビリティプロファイル

  • Advarra
  • Antidote Technologies, Inc.
  • Aris Global
  • Bsi Business Systems Integration Ag
  • Clario
  • Clinical Trials Mobile Application
  • Evidation Health, Inc.
  • HealthMatch Pty Ltd
  • Inspirata, Inc.
  • International Business Machines Corporation
  • IQVIA
  • Microsoft Corporation
  • Ofni Systems
  • PatientsLikeMe LLC
  • SSS International Clinical Research
  • Teckro
  • Tempus Labs
  • Trialbee AB
  • TrialSpark, Inc.
  • Xperii Corporation

第13章 付録

  • ディスカッションガイド
  • ライセンス・価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: DYNAMICS
  • FIGURE 2. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2021 VS 2027 (USD MILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2027
  • FIGURE 5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, 2019-2027 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, 2019-2027 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2021 VS 2027 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2021 VS 2027 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2027
  • FIGURE 12. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, 2019-2027 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, 2019-2027 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
  • FIGURE 17. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 18. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 19. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 20. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 21. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 22. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 23. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 25. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 26. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 27. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 28. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 29. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 30. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 31. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 32. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 33. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 34. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 35. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 36. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 37. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 38. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 39. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 40. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 41. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 42. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 43. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 44. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 45. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 46. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 47. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 48. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 49. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 6. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 7. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CLOUD & WEB BASED, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 10. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 12. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY END-USE, 2019-2027 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 16. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 17. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 18. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY CROS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 21. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 22. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 23. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY MEDICAL DEVICE FIRMS, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 26. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 27. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 30. AMERICAS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 31. ARGENTINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 32. BRAZIL CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 33. CANADA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 34. MEXICO CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 35. UNITED STATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 37. AUSTRALIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 38. CHINA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 39. INDIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 40. INDONESIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 41. JAPAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 42. MALAYSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 43. PHILIPPINES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 44. SINGAPORE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 45. SOUTH KOREA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 46. TAIWAN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 47. THAILAND CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 48. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 49. FRANCE CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 50. GERMANY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 51. ITALY CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 52. NETHERLANDS CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 53. QATAR CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 54. RUSSIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 55. SAUDI ARABIA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 56. SOUTH AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 57. SPAIN CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 58. UNITED ARAB EMIRATES CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 59. UNITED KINGDOM CLINICAL TRIALS MATCHING SOFTWARE MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: SCORES
  • TABLE 61. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: BUSINESS STRATEGY
  • TABLE 62. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: PRODUCT SATISFACTION
  • TABLE 63. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: RANKING
  • TABLE 64. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 65. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: MERGER & ACQUISITION
  • TABLE 66. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 67. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 68. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: INVESTMENT & FUNDING
  • TABLE 69. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 70. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET: LICENSE & PRICING
目次
Product Code: MRR-8C74ADFBFE19

The Global Clinical Trials Matching Software Market grew USD 360.72 million by 2027, at a CAGR of 13.12%.

The Global Clinical Trials Matching Software Market size was estimated at USD 172.12 million in 2021 and expected to reach USD 194.27 million in 2022, and is projected to grow at a CAGR 13.12% to reach USD 360.72 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trials Matching Software to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Deployment, the market was studied across Cloud & Web Based and On-Premise.

Based on End-use, the market was studied across CROs, Medical Device Firms, and Pharmaceuticals & Biotechnology Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trials Matching Software market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Matching Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Matching Software Market, including Advarra, Antidote Technologies, Inc., Aris Global, Bsi Business Systems Integration Ag, Clario, Clinical Trials Mobile Application, Evidation Health, Inc., HealthMatch Pty Ltd, Inspirata, Inc., International Business Machines Corporation, IQVIA, Microsoft Corporation, Ofni Systems, PatientsLikeMe LLC, SSS International Clinical Research, Teckro, Tempus Labs, Trialbee AB, TrialSpark, Inc., and Xperii Corporation.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Clinical Trials Matching Software Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Matching Software Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Matching Software Market?
  • 4. What is the competitive strategic window for opportunities in the Global Clinical Trials Matching Software Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Matching Software Market?
  • 6. What is the market share of the leading vendors in the Global Clinical Trials Matching Software Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Clinical Trials Matching Software Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for clinical trials in healthcare domain
      • 5.1.1.2. Significant requirement for precision oncology
      • 5.1.1.3. Potential demand for virtual trials and automation in the healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with accuracy of clinical trial results
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities in pharmaceuticals and biotechnology scetor
      • 5.1.3.2. Integration of artificial intelligence in clinical trial matching services
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled and experienced professionals
  • 5.2. Cumulative Impact of COVID-19

6. Clinical Trials Matching Software Market, by Deployment

  • 6.1. Introduction
  • 6.2. Cloud & Web Based
  • 6.3. On-Premise

7. Clinical Trials Matching Software Market, by End-use

  • 7.1. Introduction
  • 7.2. CROs
  • 7.3. Medical Device Firms
  • 7.4. Pharmaceuticals & Biotechnology Companies

8. Americas Clinical Trials Matching Software Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Clinical Trials Matching Software Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Clinical Trials Matching Software Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Advarra
  • 12.2. Antidote Technologies, Inc.
  • 12.3. Aris Global
  • 12.4. Bsi Business Systems Integration Ag
  • 12.5. Clario
  • 12.6. Clinical Trials Mobile Application
  • 12.7. Evidation Health, Inc.
  • 12.8. HealthMatch Pty Ltd
  • 12.9. Inspirata, Inc.
  • 12.10. International Business Machines Corporation
  • 12.11. IQVIA
  • 12.12. Microsoft Corporation
  • 12.13. Ofni Systems
  • 12.14. PatientsLikeMe LLC
  • 12.15. SSS International Clinical Research
  • 12.16. Teckro
  • 12.17. Tempus Labs
  • 12.18. Trialbee AB
  • 12.19. TrialSpark, Inc.
  • 12.20. Xperii Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing